| abstract |
The present invention relates to a pharmaceutical composition comprising a bispecific anti-MUC1/EGFR antibody-drug conjugate (EGFR x MUC1 - Hemiasterlin bispecific antibody-drug conjugate (ADC)), a polyoxyethylene-polyoxypropylene block copolymer and a buffer, particularly a pharmaceutical preparation comprising the pharmaceutical composition in the form of an aqueous solution, a frozen solution or a lyophilizate, a method of making same, as well as medical uses thereof. |